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Abstract
Background: Recognizing the importance of increased patient participation in healthcare decisions leads decision
makers to consider effective ways to incorporate patient perspectives in Health Technology Assessment (HTA)
processes. The implementation of local health HTA units in university hospitals in Quebec provides a unique opportunity
to foster an increased participation of patients in decisions regarding health technologies and clinical interventions. This
project explores strategies that could be effective in involving patients in HTA activities at the local level. To do so, three
objectives are pursued: 1) To synthesise international knowledge and experiences on patient and public involvement in
HTA activities; 2) To explore the perceptions of stakeholders (administrators, clinical managers, healthcare professionals,
HTA producers, and patients) regarding strategies for involving patients in various HTA activities; and 3) To produce a
consensual strategic framework that could guide interventions for involving patients in HTA activities at the local level.
Methods:  A systematic review of the literature will be conducted to synthesise international knowledge and
experiments regarding the implication of patients and public in HTA. Then, focus groups will be carried out with
representatives of various stakeholder groups in order to explore their perceptions regarding patient participation in
HTA. Based on findings from the systematic review and the focus groups, a framework to support patient participation
in HTA activities will be proposed. It will then be validated during a deliberative meeting with the research team,
composed of scientists and decision makers, and representatives from different groups involved in HTA in Quebec. This
deliberative meeting will aim at identifying the type and the degree of participation as well as the adequate timing for
involving patients in local HTA activities.
Discussion: Given the actual state of evidence, integrating patient perspective in HTA activities has the potential to
improve the quality of healthcare services. This study provides an opportunity to bridge the gap between HTA producers
and its ultimate end-user: the patient. It will provide guidance to support local HTA units in Quebec and elsewhere in
their decisions regarding patient participation. The framework developed could be applied to design and implement
strategies for involving patients in HTA activities.
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Background
Improving the quality of healthcare through the best sci-
entific evidence available in a context of scarce resources
is a challenge for health systems [1]. Health technology
assessment (HTA) is a multidisciplinary field of applied
research aimed at providing high-quality information
about the clinical effectiveness, cost-effectiveness, and
broader impact of drugs, medical technologies, and
health interventions in order to support and inform those
who make decisions about health policy and purchasing,
health services organisation and management, and clini-
cal practices [2,3]. In Canada, the Canadian Agency for
Drugs and Technologies in Health (CADTH), and provin-
cial agencies, such as the Agence d'évaluation des technol-
ogies et des modes d'intervention en santé (AETMIS) in
Quebec, are responsible for conducting health technology
assessments at a macroscopic level. However, HTA recom-
mendations are seldom transferred into decisions and
practices [4]. In order to favour knowledge transfer and to
support evidence-based decision making at both mes-
oscopic and microscopic levels, local HTA units have been
implemented in all five university hospitals in Quebec.
The implementation of these local HTA units is viewed as
a strategy to improve the relevance and timeliness of HTA
recommendations and, ultimately, to facilitate their
uptake [5]. This implementation could thus favour a cul-
ture of evaluation in university hospitals, which is coher-
ent with the promotion and uptake of effective healthcare
decisions.
Effective healthcare decisions are more and more concep-
tualised as the best course of action given the current sci-
entific evidence, healthcare resources, clinical
circumstances, and patient preferences [6]. With the
increased emphasis on the engagement of patients as full
partners in their care, there is a need to determine effective
ways to involve them in the decision process [7,8]. It is
expected that the need for "patient guidance will only
increase as clinical options multiply and the world of informa-
tion continues its rapid growth" [9]. This is congruent with
the fact that several HTA agencies and academics associ-
ated with HTA are now considering ways to incorporate
the perspectives of patients in their methods, thus calling
for patient-centred HTA [10,11].
The literature proposes different terms to refer to the vari-
ous groups of end-users of HTA, such as patients, consum-
ers, citizens and public. There is a lack of terminological
consensus with the term public involvement. The analysis
by Gauvin [12] identified six publics that he grouped into
two categories. Publics "whose role is to provide a societal or
lay perspective about health technologies" constitute the first
category that includes citizens, groups representing citi-
zens, and other representatives such as elected officials.
The second category consists of "those publics directly
affected by a given health condition or health technology" and
includes individual patients, services users, and the enti-
ties representing them [12]. According to Cayton [13],
these two categories could be considered as the two sides
of the same coin because they represent different roles
individuals could take when they engage with health serv-
ices. However, according to Gauvin [12], most experts in
HTA believe that the broader perspective of citizen is more
likely to be involved in the organizational and policy-
making domains and the perspective of patients and serv-
ice users in the research domain. In this last domain,
patients and service users are better positioned to high-
light matters relevant to service users such as social and
ethical consideration, patient acceptance of the technol-
ogy, and psychological implications. In this study, we are
interested mainly by patients because they are the group
most directly affected by HTA decisions, and their unique
insight can most usefully contribute to the HTA process.
They could provide 'experiential' evidence to the HTA
process [14]. We include members of the public (i.e citi-
zens) in our literature review because of their role in some
HTA activities and given the lack of terminology consen-
sus about these terms. However, the other stages of the
project are focusing more precisely on the patients.
The value of an increased participation of patients in
healthcare decisions is now recognised and leads decision
makers to consider effective ways or strategies to incorpo-
rate patients' perspectives in decision making processes.
Gaps in knowledge this study is addressing
Although opportunities to favour patient participation in
HTA activities are increasingly considered [11,15], few
experiences of patient involvement in HTA appear to be
reported in the literature [16]. Furthermore, these experi-
ences mostly concern national HTA agencies, such as
NICE and NCCHTA in England [17,18] and DACEHTA in
Denmark [19]. Also, few studies have examined the partic-
ipation of patients, consumers, or the general public in
priority setting regarding health technologies [20-22]. To
the best of our knowledge, patient involvement in univer-
sity hospital-based HTA units has not been studied yet.
According to a survey among Canadian health consumer
groups representing various diseases or conditions,
respondents reported a desire for greater involvement in
HTA, and provided feedback on mechanisms for facilitat-
ing their participation [23]. The HTA program of the
Alberta Heritage Foundation for Medical Research in Can-
ada has identified a need for greater public involvement in
its strategic planning, particularly for the identification of
potential topics of investigation [24]. Other countries,
such as England [18] and Denmark [19], have also sug-
gested increased citizen and patient participation in HTA.
However, several gaps in knowledge remain in order to
support the implication of patients in HTA. These gaps
concern, for instance, the willingness of patients andBMC Health Services Research 2009, 9:54 http://www.biomedcentral.com/1472-6963/9/54
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members of the public to be involved in healthcare deci-
sions, including the nature of their involvement [25], the
attitude of healthcare professionals regarding patient
involvement [26-28] and the absence of proven effective
strategies to guide their implication [29,30].
Goal, objectives and conceptual framework
The aim of this project is to explore how the patient per-
spective could be introduced into the structures and activ-
ities of a local HTA unit. To do so, three objectives are
proposed: 1 – To synthesise international knowledge and
experiences on patient and public involvement in HTA
activities; 2 – To explore the perceptions of stakeholders
(administrators, clinical managers, health professionals,
HTA producers, and patients) regarding patient participa-
tion in the various HTA activities, effective strategies to
support their participation, as well as barriers and facilita-
tors to this participation; and 3 – To produce a consensual
framework to guide interventions supporting patient par-
ticipation in HTA activities at the local level. The research
will use analytical frameworks developed in the field of
patient involvement in clinical decision making [31,32]
and public participation in research and HTA activities
[11,12,23,33] for each objective of the research.
Methods/Design
Two local HTA units participate in this study. One is
located at the Quebec City University Medical Centre and
the other one, at the Sherbrooke University Medical Cen-
tre. The implementation of these two local HTA units pro-
vides a unique opportunity to assess the feasibility of
introducing patient perspectives in hospital HTA activi-
ties.
Globally, we adopt a pluralist action research strategy [34]
that will allow constant adjustments between research
objectives, methods, data collection, and analysis. This
strategy seems the most appropriate, given the specific
nature of the partnership between researchers and deci-
sion makers in this project. With regards to utility for deci-
sion making, this collaboration between researchers and
decision makers is fundamental. The role of decision
makers is to ensure the appropriateness of the research
questions, objectives, methods, analysis, and outcomes to
the context, and the relevance of the research for its poten-
tial beneficiaries. Researchers have a role of facilitators in
order to translate decision makers' needs into a systematic
and rigorous research process and to analyse factors influ-
encing the decision-making behaviours.
Phase one: Systematic review of international experiences 
of involving patients in HTA
For Objective 1, a systematic review of the scientific liter-
ature (qualitative, quantitative and mixed-methods stud-
ies) and other published documentation (technical or
grey literature) will be conducted to document interna-
tional experiences regarding patient involvement in HTA.
It will also consider the concept of public involvement
that is broader and allows the inclusion of various levels,
types and contexts of involvement of different types of
public. This review will synthesise knowledge on the strat-
egies and activities regarding patient and public involve-
ment in HTA, and the potential impact of this
involvement, notably on clinical interventions, costs,
timeframes, and perceptions of other stakeholder groups.
Previous reviews and syntheses by researchers of the team
[26,35-39] will guide the elaboration of the search strate-
gies. Standardised literature searches will be conducted in
all relevant databases (PubMed, Embase, CINAHL, Psy-
cINFO, Cochrane Library, Science Citation Abstract,
Social Science Citation Asbtract, Business Source Premier,
ABI/Inform, Dissertation Abstract) and in the Interna-
tional Journal of Technology Assessment in Health Care
(IJTAHC). Relevant references from studies found
through the above sources will be followed up and
obtained for assessment. Other literature will be identi-
fied through Internet search engines and governments'
websites. Finally, publications citing the selected articles
as well as other articles by authors of the selected articles
will be searched through the ISI Science Citation Index.
The sensibility of the search strategy will be validated by
ensuring that all relevant articles identified by team mem-
bers (including decision makers and researchers) are
retrieved. Experts in the field of HTA will be contacted for
unpublished studies. The diversity of interests and exper-
tise among team researchers and their respective networks
will ensure that all relevant literature is covered.
After a first selection of potentially relevant articles, full
text copies of these papers will be retrieved and screened
independently by one of the two principal investigators
(MPG and FL) and a research assistant to assess which
studies fit the inclusion criteria. Then, each study will be
independently abstracted by teams of two reviewers
among the team researchers.
Studies will be abstracted and appraised using consensual
guidelines for narrative syntheses and meta-analytical
techniques [40-43]. Findings will be reported using
frameworks that propose models of patient and public
involvement in HTA [11,23,33]. The main characteristics
that will be extracted include: the type and the level of
involvement as well as the timing. Other elements, such as
effects on participants and on decisions about HTA, as
well as factors facilitating or limiting patient participation
will also be considered.
Phase two: Focus groups on patient participation in HTA
For Objective 2, focus groups will be conducted among
representatives of the various groups of stakeholdersBMC Health Services Research 2009, 9:54 http://www.biomedcentral.com/1472-6963/9/54
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involved in the project (hospital administrators, clinical
managers, healthcare professionals, HTA producers, and
patients) to explore their perceptions regarding patient
participation in HTA. A semi-structured guide will be used
to explore participants' perceptions about the importance
and relevance of each model of patient participation
found in the literature, as well as the applicability of the
model to the specific context of hospital-based HTA.
Focus groups will also explore participants' knowledge,
beliefs, and attitudes toward patient participation in HTA,
and specific questions will be asked about the desired type
of patient participation given the specific technology or
clinical intervention considered. A total of five focus
groups are expected with a number of participants varying
from 5 to 8, as recommended by experts [44,45]. Potential
participants will be identified through the contact net-
work method, which consists of contacting a representa-
tive of each group concerned and asking him or her to
identify potential participants [46] who will be invited to
take part in the project. Informed consent will be sought
from all participants. The focus groups will last approxi-
mately two hours and will be recorded, with the consent
of participants.
All information obtained from focus groups will be tran-
scribed verbatim and qualitative analyses will be performed
with N*Vivo. The method proposed by Huberman & Miles
[47] will guide the analyses. This method identifies three
steps in qualitative data analysis: coding, organisation and
correlation of data. Qualitative data will be coded accord-
ing to predefined variables from the analytical frameworks
used, but will also allow the identification of emerging
themes. During the initial stages of the analysis, two of the
researchers will independently code the transcripts, and
codification will be compared between them in order to
enhance the reliability of the coding. In case of divergence,
a third researcher will be consulted and a consensus will be
obtained through discussion. Furthermore, three represent-
atives from each study group will be invited to comment a
first draft of the report so that their interpretation of find-
ings and their suggestions for recommendations could be
incorporated.
Phase three: A consensual framework to guide intervention
For Objective 3, a preliminary report presenting the key
results of the systematic review and the focus groups,
including a framework of reference to support patient par-
ticipation in HTA activities, will be presented and dis-
cussed during a deliberative meeting. This meeting will
bring together all members of the research team, research-
ers and decision makers collaborating to the project, rep-
resentatives of other HTA units across the province of
Quebec, and patient representatives. Between 8 and 10
participants are expected to attend the meeting. As pro-
posed by Pagliari et al. [48], the three stages of group deci-
sion making will be followed: 1) definition of the
problem; 2) discussion of possible alternatives; 3) deci-
sion. The results of the systematic review and the focus
groups will be first presented and a strategic framework
for patient participation in HTA will be proposed. Partici-
pants will be invited to share their opinions about the rel-
evance and applicability of the proposed models and
strategies to support patient participation in HTA. This
deliberative meeting will allow direct interaction between
researchers and stakeholders about models found in the
literature and the relevance of the proposed framework to
their reality. This meeting will also allow the clarification
of the major points of consensus and disagreement in
order to estimate the robustness and the transferability of
the results [41,49], as well as the questions that require
more extensive research [50].
Following the deliberative meeting, the proposed strategic
framework will be enhanced by combining knowledge
about models of patient participation found in the litera-
ture, specific characteristics of the context from the focus
groups and the deliberative meeting. The core compo-
nents of this strategic framework will be the type of partic-
ipation, the degree of involvement, and the timing. This
framework will be used in the development of strategies
aiming at the participation of patients in specific HTA
activities and will guide the evaluation of outcomes in the
following phase of this research program. This framework
could easily be transferred to other HTA institutions in
Quebec and outside the province. This framework could
also constitute a useful guide to support decision making
regarding the implication of patients in other domains,
such as prioritisation in risk management strategies or
policies on the management and control of infections.
Knowledge translation (KT) plan
This project aims at producing usable knowledge that
could support decision makers responsible for HTA activ-
ities. According to a systematic review of factors determin-
ing knowledge application in decision making,
interactions between researchers and healthcare policy
makers and timing/timeliness are two factors that mostly
appear to increase research use [51]. Our approach to
knowledge translation is based on these two key-elements
and is organised around three broad strategies.
The first strategy is the participation of stakeholders in
each phase of the project. Notably, decision makers are
involved in the elaboration of research objectives, the
choice of the methodology, and the analysis and interpre-
tation of results. To do so, workshops will be held with
decision makers on the research team through a participa-
tory approach [52]. These workshops will take place at key
moments before and after each phase of the project. These
transfer activities will allow the validation of researchBMC Health Services Research 2009, 9:54 http://www.biomedcentral.com/1472-6963/9/54
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products according to decision makers' needs and com-
ments. This strategy aims to ensure that the results are use-
ful and usable to support decision making processes. The
participation of decision makers in the formulation and
implementation of research represents, according to
Lomas [53], the best predictive element of the application
of knowledge resulting from research.
The second strategy involves a representative of patients in
HTA activities. This representative will participate in the
meetings of the project team in order to validate the
research processes. In addition, other representatives of
patients will be solicited during the course of the project
to take part in a focus group on their perceptions about
patient participation in HTA activities. This direct partici-
pation of patient representatives will allow the considera-
tion of their preferences in the proposed strategies.
Moreover, the deliberative meeting will allow direct
exchanges between hospital administrators, clinical man-
agers, HTA producers and patients' representatives. This
activity will allow the discussion of research findings in
order to ensure that they are uniformly understood by all
groups and are relevant to their decision-making needs.
Following this deliberative meeting, consensual key mes-
sages will be elaborated for larger diffusion [54].
Finally, the third strategy is the transfer of research results
to other HTA units in Quebec, and to other groups
involved in HTA in Canada and elsewhere. This transfer
will be done through participation of representatives from
other HTA units of the province in the focus groups and
the deliberative meeting. Collaborators from HTA agen-
cies in other countries will also be informed about this
initiative and their feedback will be sought through work-
shops organised at international HTA meetings.
At the end of the project, we will organise a provincial
symposium targeting key decision makers (policy makers,
managers and professionals) from the UETMIS, AETMIS
and CADTH. This will be a unique occasion for all groups
involved in HTA in the province of Quebec to present and
share their research experiences with other teams. The
symposium proceedings and presentations will be availa-
ble on the Web through an open access. Decision makers
from the Ministry of Health and regional health authori-
ties will also be invited to this symposium.
Evaluation of the knowledge translation plan
To evaluate the impact of the proposed KT plan, we will
adapt a tool that was developed by Skinner [55] to meas-
ure knowledge exchange outcomes. This tool is based on
a conceptual framework proposed by Knott & Wildavsky
[56] and adapted by Landry et al. [57,58] The extent of
knowledge application regarding patient participation in
HTA activities will be measured based on a scale that will
be developed in this study. The criteria to judge whether
knowledge is adapted to the context and needs of stake-
holders will be elaborated for each group. In order to
ensure a formative evaluation of the different KT activities,
a short questionnaire will be distributed to participants at
the end of each activity. To measure the effective use of
knowledge resulting from our research in decision making
processes, we propose an approach based on the psycho-
social determinants of human behaviours to evaluate the
relevance of knowledge resulting from research from the
perspective of the targeted audience, as well as their inten-
tion to use this knowledge to support their decision mak-
ing. The questionnaire will require approximately 10
minutes to fill out. Its content will be analysed at the end
of the project in order to measure the intention of deci-
sion makers to use the results in their practice.
Ethical considerations
All data collected for the document analysis in this study
will be obtained from publicly available sources. Partici-
pants in the focus groups (phase 2) will be asked to com-
plete a consent form presenting research objectives and
information about research implications. Ethics approval
for the project has been received from the Research Ethics
Board of the Centre Hospitalier Universitaire de Québec
(approved December 18 2008; ethics number 5-08-12-05).
Discussion
This study will be the first, to the best of our knowledge,
to systematically review international experiences on
patient participation in HTA, and to propose a framework
that will support the development of a guide to support
local HTA units in their decisions regarding patient partic-
ipation. It will also explore the perceptions of various HTA
stakeholders regarding the implication of patients in
healthcare decisions.
This study is being conducted in close collaboration with
decision makers in order to allow constant linkages that
are likely to favour the relevance and utilisation of
research results. Based on results from the literature
review, focus groups, and deliberative meeting, effective
strategies for supporting patient participation in HTA will
be identified. A subsequent phase of this project could be
the implementation of such strategies in the local HTA
unit of university hospitals of Quebec. Thus, this research
is an essential first step to ensure the feasibility of intro-
ducing patient participation in HTA.
Also, members of our research team are involved in two
other knowledge syntheses that share a similar focus. One
deals with patient perspectives on an electronic health
record [59]. The other deals with patients and public
involvement in clinical practice guidelines [60].
Given the actual state of evidence, promoting patient par-
ticipation in HTA could improve the quality and safety ofBMC Health Services Research 2009, 9:54 http://www.biomedcentral.com/1472-6963/9/54
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healthcare. This project provides an opportunity to bridge
the gap between the producers of HTA and its ultimate
end-user: the patient. The knowledge that will be pro-
duced will be extremely useful for policy makers, health-
care managers, and academics interested in HTA
nationally and internationally, as well as for the larger
community of people interested in the active participation
of citizens and patients in healthcare decision making.
This project directly aligns with at least three of the Cana-
dian Institutes of Health Research strategic priority
research areas: 1) it will provide innovative insight on
how to successfully involving the public in decision mak-
ing and, in particular, strategies for engaging the public in
priority-setting; 2) it will reinforce a patient-centred care
approach in focusing on the participation and involve-
ment of patients; and 3) it will serve as a strategy to
increase quality of care and patient safety [61].
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